Gulf Cooperation Council Clinical Trials in the Pursuit of Medications for COVID-19

Bassam Ali Jaber; Mowafa Househ; Zubair Shah; M. Sohel Rahman; Mounir Hamdi; Kabir H. Biswas; Tanvir Alam

doi:10.3233/SHTI210846

Gulf Cooperation Council Clinical Trials in the Pursuit of Medications for COVID-19

Bassam Ali Jaber, Mowafa Househ, Zubair Shah, M. Sohel Rahman, Mounir Hamdi, Kabir H. Biswas, Tanvir Alam^*

^*Corresponding author for this work

Research output: Chapter in Book/Conference Proceeding/Report › Conference Paper published in a book › peer-review

2 Citations (Scopus)

Abstract

Tremendous changes have been witnessed in the post-COVID-19 world. Global efforts were initiated to reach a successful treatment for this emerging disease. These efforts have focused on developing vaccinations and/or finding therapeutic agents that can be used to combat the virus or reduce its accompanying symptoms. Gulf Cooperation Council (GCC) countries have initiated efforts on many clinical trials to address the efficacy and the safety of several therapeutic agents used for COVID-19 treatment. In this article, we provide an overview of the GCC's clinical trials and associated drugs' discovery process in the pursuit of an effective medication for COVID-19.

Original language	English
Title of host publication	Informatics and Technology in Clinical Care and Public Health
Editors	John Mantas, Arie Hasman, Mowafa S. Househ, Parisis Gallos, Emmanouil Zoulias, Joseph Liasko
Publisher	IOS Press BV
Pages	9-13
Number of pages	5
ISBN (Electronic)	9781643682501
DOIs	https://doi.org/10.3233/SHTI210846
Publication status	Published - 2022
Externally published	Yes

Publication series

Name	Studies in Health Technology and Informatics
Volume	289
ISSN (Print)	0926-9630
ISSN (Electronic)	1879-8365

Bibliographical note

Publisher Copyright:
© 2022 The authors and IOS Press.

Keywords

COVID-19
Coronavirus
Drug
GCC
Qatar

UN SDGs

This output contributes to the following UN Sustainable Development Goals (SDGs)

Access to Document

10.3233/SHTI210846

Cite this

Jaber, B. A., Househ, M., Shah, Z., Rahman, M. S., Hamdi, M., Biswas, K. H., & Alam, T. (2022). Gulf Cooperation Council Clinical Trials in the Pursuit of Medications for COVID-19. In J. Mantas, A. Hasman, M. S. Househ, P. Gallos, E. Zoulias, & J. Liasko (Eds.), Informatics and Technology in Clinical Care and Public Health (pp. 9-13). (Studies in Health Technology and Informatics; Vol. 289). IOS Press BV. https://doi.org/10.3233/SHTI210846

Jaber, Bassam Ali ; Househ, Mowafa ; Shah, Zubair et al. / Gulf Cooperation Council Clinical Trials in the Pursuit of Medications for COVID-19. Informatics and Technology in Clinical Care and Public Health. editor / John Mantas ; Arie Hasman ; Mowafa S. Househ ; Parisis Gallos ; Emmanouil Zoulias ; Joseph Liasko. IOS Press BV, 2022. pp. 9-13 (Studies in Health Technology and Informatics).

@inproceedings{dda2aad7b14c4557acb327dcf8beb0a2,

title = "Gulf Cooperation Council Clinical Trials in the Pursuit of Medications for COVID-19",

abstract = "Tremendous changes have been witnessed in the post-COVID-19 world. Global efforts were initiated to reach a successful treatment for this emerging disease. These efforts have focused on developing vaccinations and/or finding therapeutic agents that can be used to combat the virus or reduce its accompanying symptoms. Gulf Cooperation Council (GCC) countries have initiated efforts on many clinical trials to address the efficacy and the safety of several therapeutic agents used for COVID-19 treatment. In this article, we provide an overview of the GCC's clinical trials and associated drugs' discovery process in the pursuit of an effective medication for COVID-19.",

keywords = "COVID-19, Coronavirus, Drug, GCC, Qatar",

author = "Jaber, \{Bassam Ali\} and Mowafa Househ and Zubair Shah and Rahman, \{M. Sohel\} and Mounir Hamdi and Biswas, \{Kabir H.\} and Tanvir Alam",

note = "Publisher Copyright: {\textcopyright} 2022 The authors and IOS Press.",

year = "2022",

doi = "10.3233/SHTI210846",

language = "English",

series = "Studies in Health Technology and Informatics",

publisher = "IOS Press BV",

pages = "9--13",

editor = "John Mantas and Arie Hasman and Househ, \{Mowafa S.\} and Parisis Gallos and Emmanouil Zoulias and Joseph Liasko",

booktitle = "Informatics and Technology in Clinical Care and Public Health",

}

Jaber, BA, Househ, M, Shah, Z, Rahman, MS, Hamdi, M, Biswas, KH & Alam, T 2022, Gulf Cooperation Council Clinical Trials in the Pursuit of Medications for COVID-19. in J Mantas, A Hasman, MS Househ, P Gallos, E Zoulias & J Liasko (eds), Informatics and Technology in Clinical Care and Public Health. Studies in Health Technology and Informatics, vol. 289, IOS Press BV, pp. 9-13. https://doi.org/10.3233/SHTI210846

Gulf Cooperation Council Clinical Trials in the Pursuit of Medications for COVID-19. / Jaber, Bassam Ali; Househ, Mowafa; Shah, Zubair et al.
Informatics and Technology in Clinical Care and Public Health. ed. / John Mantas; Arie Hasman; Mowafa S. Househ; Parisis Gallos; Emmanouil Zoulias; Joseph Liasko. IOS Press BV, 2022. p. 9-13 (Studies in Health Technology and Informatics; Vol. 289).

Research output: Chapter in Book/Conference Proceeding/Report › Conference Paper published in a book › peer-review

TY - GEN

T1 - Gulf Cooperation Council Clinical Trials in the Pursuit of Medications for COVID-19

AU - Jaber, Bassam Ali

AU - Househ, Mowafa

AU - Shah, Zubair

AU - Rahman, M. Sohel

AU - Hamdi, Mounir

AU - Biswas, Kabir H.

AU - Alam, Tanvir

PY - 2022

Y1 - 2022

N2 - Tremendous changes have been witnessed in the post-COVID-19 world. Global efforts were initiated to reach a successful treatment for this emerging disease. These efforts have focused on developing vaccinations and/or finding therapeutic agents that can be used to combat the virus or reduce its accompanying symptoms. Gulf Cooperation Council (GCC) countries have initiated efforts on many clinical trials to address the efficacy and the safety of several therapeutic agents used for COVID-19 treatment. In this article, we provide an overview of the GCC's clinical trials and associated drugs' discovery process in the pursuit of an effective medication for COVID-19.

AB - Tremendous changes have been witnessed in the post-COVID-19 world. Global efforts were initiated to reach a successful treatment for this emerging disease. These efforts have focused on developing vaccinations and/or finding therapeutic agents that can be used to combat the virus or reduce its accompanying symptoms. Gulf Cooperation Council (GCC) countries have initiated efforts on many clinical trials to address the efficacy and the safety of several therapeutic agents used for COVID-19 treatment. In this article, we provide an overview of the GCC's clinical trials and associated drugs' discovery process in the pursuit of an effective medication for COVID-19.

KW - COVID-19

KW - Coronavirus

KW - Drug

KW - GCC

KW - Qatar

UR - https://www.scopus.com/pages/publications/85123206155

U2 - 10.3233/SHTI210846

DO - 10.3233/SHTI210846

M3 - Conference Paper published in a book

C2 - 35062079

AN - SCOPUS:85123206155

T3 - Studies in Health Technology and Informatics

SP - 9

EP - 13

BT - Informatics and Technology in Clinical Care and Public Health

A2 - Mantas, John

A2 - Hasman, Arie

A2 - Househ, Mowafa S.

A2 - Gallos, Parisis

A2 - Zoulias, Emmanouil

A2 - Liasko, Joseph

PB - IOS Press BV

ER -

Jaber BA, Househ M, Shah Z, Rahman MS, Hamdi M, Biswas KH et al. Gulf Cooperation Council Clinical Trials in the Pursuit of Medications for COVID-19. In Mantas J, Hasman A, Househ MS, Gallos P, Zoulias E, Liasko J, editors, Informatics and Technology in Clinical Care and Public Health. IOS Press BV. 2022. p. 9-13. (Studies in Health Technology and Informatics). doi: 10.3233/SHTI210846

Gulf Cooperation Council Clinical Trials in the Pursuit of Medications for COVID-19

Abstract

Publication series

Bibliographical note

Keywords

UN SDGs

Access to Document

Other files and links

Fingerprint

Cite this